Cargando…
Hypnotics' association with mortality or cancer: a matched cohort study
OBJECTIVES: An estimated 6%–10% of US adults took a hypnotic drug for poor sleep in 2010. This study extends previous reports associating hypnotics with excess mortality. SETTING: A large integrated health system in the USA. DESIGN: Longitudinal electronic medical records were extracted for a one-to...
Autores principales: | Kripke, Daniel F, Langer, Robert D, Kline, Lawrence E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293137/ https://www.ncbi.nlm.nih.gov/pubmed/22371848 http://dx.doi.org/10.1136/bmjopen-2012-000850 |
Ejemplares similares
-
Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
por: Kripke, Daniel F.
Publicado: (2018) -
Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study
por: Reis, Margareta, et al.
Publicado: (2013) -
What do hypnotics cost hospitals and healthcare?
por: Kripke, Daniel F.
Publicado: (2017) -
Greater incidence of depression with hypnotic use than with placebo
por: Kripke, Daniel F
Publicado: (2007) -
Is suvorexant a better choice than alternative hypnotics?
por: Kripke, Daniel F.
Publicado: (2015)